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Autochthonous leprosy has been reported in New York City, 
where there are no wild armadillos. Recent autochthonous 
cases also have been reported in Georgia and Florida and 
blamed on armadillos, including cases with no known arma-
dillo exposure. International migration needs to be consid-
ered as a cause of autochthonous leprosy.
In 1982, we reported that leprosy in New York City oc-curred exclusively among foreign-born persons (1). In 
1991, Mastro et al. reported that leprosy was an epidemic 
phenomenon without secondary transmission (2). In 2000, 
however, the first autochthonous cases of leprosy in New 
York City were reported (3), and 2 additional autochtho-
nous cases subsequently were reported (4,5). Autochtho-
nous leprosy has been reported in the eastern United States 
in Georgia (6) and central Florida (7); transmission was 
blamed on armadillos, even though most of these case-pa-
tients had no history of exposure to armadillos, and arma-
dillos east of the Mississippi River rarely have leprosy (8).
Although the transmission of leprosy is poorly under-
stood, international migration of persons with leprosy is a 
more likely scenario for autochthonous transmission than 
contact with armadillos, especially if a case-patient has 
no history of armadillo exposure. Ramos et al. linked an 
increase in autochthonous leprosy in Spain to a 5-fold in-
crease in migration from countries where leprosy is preva-
lent (9). There are no wild armadillos in New York City. 
Autochthonous cases of leprosy reported from the eastern 
United States should not be assumed to be from armadillos. 
Physicians throughout the United States need to be aware 
that leprosy can occur in native-born Americans and that 
delayed diagnosis, which occurs frequently, can result in 
unacceptable deformities.
Leprosy most commonly is characterized by an in-
filtrative dermopathy, which dermatologists and many 
physicians know is an indication for skin biopsy. Many 
otherwise highly trained physicians are not aware of this 
indication for a skin biopsy, which is required to diagnose 
leprosy. This indication is routinely taught in dermatol-
ogy clinics, but leprosy is common enough in the United 
States that it should be incorporated into the core curricula 
of medical schools. Leprosy also can be characterized by 
fever and arthritis simulating lupus erythematosus, rheu-
matoid arthritis, or antiphospholipid syndrome because au-
toantibodies occur in type II reaction known as erythema 
nodosum leprosum. Physicians should order a Fite stain on 
the skin biopsy specimen because Mycobacterium leprae is 
sensitive to the alcohol decolorizing step; if only a routine 
acid-fast stain (Ziehl-Neelsen) is ordered, the diagnosis is 
often missed (10).
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